Kenneth Krogulski - Oct 17, 2023 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Kenneth J. Krogulski by /s/ John Hamm as attorney-in-fact
Stock symbol
CPIX
Transactions as of
Oct 17, 2023
Transactions value $
$5,753
Form type
4
Date filed
11/3/2023, 05:02 PM
Previous filing
Oct 17, 2023
Next filing
Nov 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $627 +280 +0.13% $2.24 222K Oct 17, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $549 +280 +0.13% $1.96 223K Oct 18, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $574 +280 +0.13% $2.05 223K Oct 19, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $133 +64 +0.03% $2.08 223K Oct 20, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $530 +255 +0.11% $2.08 223K Oct 23, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $588 +280 +0.13% $2.10 224K Oct 24, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $557 +280 +0.13% $1.99 224K Oct 25, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $557 +280 +0.13% $1.99 224K Oct 26, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $554 +280 +0.12% $1.98 224K Oct 27, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $520 +255 +0.11% $2.04 225K Oct 30, 2023 Direct F1
transaction CPIX Common Stock Small acquisition under Rule 16a-6 $563 +280 +0.12% $2.01 225K Oct 31, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023.